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Abstract. 3-Hydroxypyridine undergoes a smooth reaction with dialkyl acetylenedicarboxylates in the presence 
of triphenylphosphine to produce alkyl 2-oxo-2H-pyrano[3,2-b]pyridine-4-carboxylate and dialkyl -2-[4-
(alkoxycarbonyl)-2-oxo-2-H-pyrano[3,2-b]pyridin-6-yl]-2-butenedioate in high yields. (doi: 10.5562/cca1725) 
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INTRODUCTION 
Coumarins are of interest because they constitute an 
important class of naturally occurring compounds, many 
of which exhibit useful and diverse biological activity.1 
In addition, other coumarins are of much interest a re-
sult of their toxicity,2 carcinogenicity,3 and photodyna-
mic effects.4 In particular, those coumarins fused to 
pyridines have been reported to possess antiallergic,5 
antidiabetic,6 and analgesic properties.7 Also, a consi-
derable number of natural or synthetic derivatives of 
coumarin have found pharmaceutical applications.8,9 
Thus, the synthesis of this heterocyclic nucleus is of 
current interest. Coumarins and aza cumarins have been 
synthesized by several methods.10–14 We have recently 
described a new and operationally convenient approach 
to the synthesis of carboxymethyl coumarines based on 
aromatic electrophilic substitution reaction between the 
conjugate base of substituted phenols, catechol, resorci-
nol, hydroquinone, and pyrogallol.15,16 In continuation 
of our current interest in the development of new routes 
to heterocyclic and carbocyclic systems,17–19 we report 
here a simple one-pot synthesis of functionalized 5-Aza 
coumarines 3, 4. Thus, reaction of 3-hydroxypyridine 1 
with dialkyl acetylenedicarboxylate 2 in the presence of 
triphenylphosphine leads to the corresponding couma-
rins 3, 4 (Scheme 1). 
 
RESULT AND DISCUSSION 
The reaction of 2-hydroxy pyridine (1) with dialkyl 
acetylenedicarboxylate (2) in the presence of Ph3P pro-
ceeded spontaneously in toluene at reflux temperature 
and needed within 24 h to finish. On the other condi-
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either did not have any considerable effect on 3 and 4 
yields or it caused reaction failed to proceed. The 
products were separated by column chromatography 
and identified as 3 and 4 based on their elemental 
analyses and their IR, 1H, and l3C NMR spectral data. 
The mass spectra of these compounds displayed mole-
cular ion peaks at appropriate m/z values. The 1H 
NMR spectrum of 3a exhibited a single sharp line for 
the methyl group at δ = 4.04 ppm, together with singlet 
at δ = 6.84 ppm for methine proton. The aromatic 
moiety was appeared at 7.54–8.66 ppm. The 13C NMR 
spectrum of 3a showed ten distinct resonances in 
agreement with the methyl 2-oxo-2H-pyrano[3,2-
b]pyridine-4-carboxylate structure. The 1H and 13C 
NMR spectra of 3b and 3c are similar to those of 3a 
except for the alkoxy moieties, which exhibited cha-
racteristic resonances with appropriate chemical shifts. 
The 1H NMR spectrum of 4a exhibited three single 
sharp line for the methoxy group at δ = 3.84, 3.99 and 
4.05 ppm, together with two singlet at δ = 6.88 and 
6.89 ppm for methine protons. The 13C NMR spectrum 
of 4a exhibited fifteen sharp lines in agreement with 
the proposed structure. Partial assignment of these 
resonances is given in the experimental. 
Mechanistically,15,16 it is conceivable that the reac-
tion involves the initial formation of a zwitterionic in-
termediate between Ph3P and the acetylenic compound 
and subsequent protonation of reactive 1:1 adduct fol-
lowed by electrophilic attack of vinyltriphenylphospho-
nium cation on the aromatic ring at the ortho position 
relative to the strong activation group. The product is 
presumably produced by intramolecular lactonization of 
the unsaturated diester 5 (Scheme 2). 
Reaction leading to 4, involves formation of the 
zwitterionic intermediate which is protonated by 3-
hydroxypyridine. Then it is attacked by the conjugate 
base to produce ylide, in next step the intermediate 
undergoes proton transfer to furnish the 1,3-diionic 
structure. At the end, it is  converted to the final product 
by loss of Ph3P. 
 
CONCLUSION 
In conclusion, we have described a convenient route to 
aza coumarines, through nucleophilic addition to dialkyl 
acetylenedicarboxylate. These functionalised couma-
rines may be considered as potentially useful synthetic 
intermediates because they possess atoms with different 
oxidation states. The present method has the advantages 
that not only are the reaction performed under neutral 
conditions, but also the substances can be mixed with-
out any modification. The simplicity of the present 





Compounds 1, 2 and Ph3P were obtained from Fluka 
and were used without further purification. M.p. Elec-
trothermal-9100 apparatus. IR Spectra: Shimadzu IR-
460 spectrometer. 1H and 13C NMR spectra: Bruker 
DRX-500 AVANCE instrument; in CDCl3 at 300 and 
75 MHz, respectively; δ in ppm. EI-MS (70 eV): Finni-
gan-MAT-8430 mass spectrometer, in m/z. Elemental 
analyses (C, H, N) were performed with a Heraeus 
CHN-O-Rapid analyser. 
 
General Procedure for the Preparation of compound 3 
To a stirred solution of 0.52 g of Ph3P (2 mmol) and 
0.19 g 1 (2 mmol) in toluene (10 ml) was added drop 
wise a mixture of 2 (2 mmol) in toluene (2 ml) at room 
temperature over 5 min. The reaction mixture was 
heated under reflux for 24 h. The solvent was removed 
under reduced pressure, and the viscous residue was 
purified by column chromatography (SiO2; hex-
ane/AcOEt 4:1) to afford the pure adducts. 
 
Methyl 2-oxo-2H-pyrano[3,2-b]pyridine-4-carboxylate (3a) 
Yellow powder, 0.20 g (49 %); mp 128–132 °C; IR 
(KBr) νmax/cm−1: 1744(C=O), 1625 (C=N); 1H NMR 
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(dd, 1H, J = 7.1, 4.5 Hz, CH) 7.69 (d, 1H, J = 7.1, CH), 
8.66 (d, 1H, J = 4.5 Hz, CH). 13C NMR (CDCl3) δ/ppm: 
53.8 (Me), 120.1, 125.1, 126.9 (CH), 134.9, 146.8 (C), 
147.3 (CH), 151.3 (C), 159.0, 164.3 (C=O). MS (EI) 
m/z: 205 (M+, 47 %), 190 ([M-CH3]+, 68 %), 161 ([M-
CO2]+, 100), 146 ([M-CO2-CH3]+, 45 %). 
Anal. Calcd. mass fraction of elements, w/% for 
C10H7NO4 (Mr = 205.17) are: C 58.54, H 3.44, N 6.83; 




Yellow oil, 0.26 g (37 %); IR (KBr) νmax/cm−1: 1744 
(C=O), 1636 (C=N); 1H NMR (CDCl3) δ/ppm: 3.84 (s, 
3H, Me), 3.99 (s, 3H, Me), 4.05 (s, 3H, Me), 6.88 (s, 
1H, CH), 6.89 (s, 1H, CH), 7.70 (brs, 2H, 2 CH). 13C 
NMR (CDCl3) δ/ppm: 52.8, 53.3, 53.8 (Me), 120.9, 
121.4, 124.9, 125.9 (CH), 146.1, 146.6, 148.3, 151.2, 
158.3 (C), 163.7, 165.4, 167.6 (C=O); MS (EI) m/z: 347 
(M+, 37 %), 303 ([M-CO2]+, 84 %), 292 ([M-3CH3]+, 
100 %), 288 ([M-CO2-CH3]+, 15 %), 204 ([M-C6H7O4]+, 
39 %), 170 ([M-3CO2-CH3]+, 100 %). 
Anal. Calcd. mass fraction of elements, w/% for 
C16H13NO8 (Mr = 347.28) are: C 55.34, H 3.77, N 4.03; 




Yellow powder, 0.18 g (41 %); mp 119–121 °C.IR 
(KBr) νmax/cm−1: 1740 (C=O), 1634 (C=N); 1H NMR 
(CDCl3) δ/ppm: 1.44 (t, 3H, J = 7.1 Hz, Me), 4.52 (q, 
2H, J = 7.1 Hz, OCH2), 6.83 (s, 1H, CH), 7.53 (dd, 1H, 
J = 7.1, 4.5 Hz, CH), 7.69 (d, 1H, J = 7.1, Hz, CH), 8.66 
(d, 1H, J = 4.5 Hz, CH). 13C NMR (CDCl3) δ/ppm: 14.5 
(Me), 63.2 (OCH2), 119.7, 125.1, 126.8 (CH), 139.3, 
147.1 (C), 147.3 (CH), 151.3 (C), 159.1, 163.8 (C=O). 
MS (EI) m/z: 219 (M+, 18 %), 190 ([M-CH3]+, 51 %), 
175 ([M-CO2]+, 90 %), 146 ([M-CO2-C2H5]+, 68 %). 
Anal. Calcd. mass fraction of elements, w/% for 
C11H9NO4 (Mr = 219.19) are: C 60.28, H 4.14, N 6.39; 




Yellow oil, 0.30 g (39 %). IR (KBr) νmax/cm−1: 1728 
(C=O), 1624 (C=N); 1H NMR (CDCl3) δ/ppm: 1.35 (t, 
3H, J = 7.0 Hz, Me), 1.41 (t, 3H, J = 7.0 Hz, Me), 1.47 
(t, 3H, J = 7.1 Hz, Me), 4.29 (q, 2H, J = 7.1 Hz, OCH2), 
4.46 (q, 2H, J = 7.1 Hz, OCH2), 4.52 (q, 2H, J = 7.1 Hz, 
OCH2), 6.87 (s, 1H, CH), 6.92 (s, 1H, CH), 7.69 (brs, 
2H, 2 CH). 13C NMR (CDCl3) δ/ppm: 14.4, 14.5, 14.6 
(Me), 61.7, 62.5, 63.2 (OCH2), 120.5, 122.1, 125.5, 
125.8 (CH), 145.5, 147.1, 148.5, 151.2, 158.5 (C), 
163.5, 165.0, 167.1 (C=O). MS (EI) m/z: 389 (M+, 26 
%), 345 ([M-CO2]+, 77 %), 316 ([M-CO2-C2H5]+, 48 
%), 302 ([M-3C2H5]+, 59 %), 218 ([M-C8H11O4]+, 76  
 
%), 170 ([M-3CO2-C2H5]+, 100 %). 
Anal. Calcd. mass fraction of elements, w/% for 
C19H19NO8 (Mr = 389.36) are: C 58.61, H 4.92, N 3.60; 




Yellow powder, 0.22 g (48 %). mp 125–128 °C. IR 
(KBr) νmax/cm−1: 1742 (C=O), 1622 (C=N); 1H NMR 
(CDCl3) δ/ppm: 1.43 (d, 6H, J = 6.0 Hz, 2Me), 5.41 
(sept, 1H, J = 6.2 Hz, OCH), 7.52 (dd, 1H, J = 7.1, 4.5 
Hz, CH), 7.67 (d, 1H, J = 7.1 Hz, CH), 8.66 (d, 1H, J = 
4.5 Hz, CH). 13C NMR (CDCl3) δ/ppm: 22.2 (2Me), 
71.2, 119.3, 124.9, 126.7 (CH), 135.5 (C), 147.3 (CH), 
147.5, 151.3 (C), 159.1, 163.3 (C=O). MS (EI) m/z: 233 
(M+, 12 %), 190 ([M-C3H7]+, 35 %), 189 ([M-CO2]+, 58 
%), 146 ([M-CO2-C3H7]+, 100 %). 
Anal. Calcd. mass fraction of elements, w/% for 
C12H11NO4 (Mr = 233.22) are: C 61.80, H 4.75, N 6.01; 
Found: C 61.33, H 5.06, N 6.42. 
 
Diisopropylyl-2-[4-(isopropoxycarbonyl)-2-oxo-2-H- 
 pyrano[3,2-b]pyridin-6-yl]-2-butenedioate (4c) 
Yellow oil, 0.29 g (34 %). IR (KBr) νmax/cm−1: 1743 
(C=O), 1634 (C=N); 1H NMR (CDCl3) δ/ppm: 1.31 (d, 
6H, J = 6.2 Hz, 2Me), 1.40 (d, 6H, J = 6.3 Hz, 2Me), 
1.45 (d, 6H, J = 6.3 Hz, 6H, 2Me), 5.12 (sept, 1H, J = 
6.3 Hz, 1H, OCH), 5.36 (sept, 1H, J = 6.2 Hz, OCH), 
5.38 (sept, 1H, J = 6.3 Hz, OCH), 6.83 (s, 1H, CH), 
6.93 (s, 1H, CH), 7.62 (d, 1H, J = 8.7 Hz, CH), 7.68 (d, 
1H, J = 8.7 Hz, CH). 13C NMR (CDCl3) δ/ppm: 22.0, 
22.2 (2Me), 69.2, 70.3, 71.4, 120.2, 122.7, 124.9, 125.7 
(CH), 145.4, 147.6, 149.0, 151.2, 158.5 (C), 163.2, 
164.4, 166.6 (C=O). MS (EI) m/z: 431 (M+, 34%), 387 
([M-CO2]+, 15 %), 344 ([M-CO2-C3H7]+, 62 %), 302 
([M-3C2H5]+, 100 %), 232 ([M-C10H15O4]+, 31 %), 170 
([M-3CO2-C2H5]+, 57 %). 
Anal. Calcd. mass fraction of elements, w/% for 
C22H25NO8 (Mr = 431.44) are: C 61.25, H 5.84, N 3.25. 




Yellow powder, 0.19 g (38 %). mp 130–132 °C. IR 
(KBr) νmax/cm−1: 1723(C=O), 1628 (C=N); 1H NMR 
(CDCl3) δ/ppm: 1.52 (s, 9H, 3Me), 6.74 (s, 1H, CH), 
7.52 (dd, 1H, J = 7.1, 3.1 Hz, CH), 7.67 (d, 1H, J = 7.1, 
Hz, CH), 8.66 (d, 1H, J = 3.1 Hz, CH). 13C NMR 
(CDCl3) δ/ppm: 28.4 (3Me), 83.6, 117.3, 118.8 (C), 
124.1 (CH), 124.8 (C), 126.6 (CH), 143.2, 147.3 (C), 
168.6, 1648.9 (C=O). MS (EI) m/z: 247 (M+, 31 %), 203 
([M-CO2]+, 21 %), 190 ([M-C4H9]+, 100 %), 146 ([M-
CO2-C4H9]+, 81 %). 
Anal. Calcd. mass fraction of elements, w/% for 
C13H13NO4 (Mr = 247.25) are: C 63.15, H 5.30, N 5.67. 
Found: C 60.89, H 5.37, N 5.73. 
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Di tert-butyl-2-[4-(tert-butoxycarbonyl)-2-oxo-2-H-py- 
rano[3,2-b]pyridin-6-yl]-2-butenedioate (4d) 
Yellow oil, 0.23 g (24 %). IR (KBr) νmax/cm−1: 
1723(C=O), 1633 (C=N); 1H NMR (CDCl3) δ/ppm: 
1.52 (s, 9H, 3Me), 1.62 (s, 9H, 3Me), 1.67 (s, 9H, 3Me), 
6.75 (s, 1H, CH), 7.00 (s, 1H, CH), 7.59 (d, 1H, J = 7.5 
Hz, CH), 7.64 (d, 1H, J = 8.7 Hz, CH). 13C NMR 
(CDCl3) δ/ppm: 28.4, 28.5, 28.6 (3Me), 81.7, 83.7, 85.3 
(C), 119.1, 124.0, 125.0, 125.5 (CH), 144.6, 148.4, 
148.7, 151.1, 158.9 (C), 163.0, 164.3, 166.3 (C=O). MS 
(EI) m/z: 473 (M+, 12 %), 429 ([M-CO2]+, 44 %), 372 
([M-CO2-C4H9]+, 24 %), 302 ([M-3C4H9]+, 89 %), 246 
([M-C12H19O4]+, 58 %), 170 ([M-3CO2-C4H9]+, 100 %). 
Anal. Calcd. mass fraction of elements, w/% for 
C25H31NO8 (Mr = 473.52) are: C 63.41, H 6.60, N 2.96. 
Found: C 63.97, H 6.31, N 3.12. 
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